OptimumBank Holdings, Inc. Financial Performance for the Third Quarter of 2026

OptimumBank Holdings, Inc. (OPHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 OptimumBank Holdings, Inc. Financial Performance for the Third Quarter of 2026 Fort Lauderdale, FL, November 12, 2026 — OptimumBank Holdings, Inc. (NYSE American: OPHC) (the “Company”) is a financial holding company and owns 100% of OptimumBank (the “Bank”), a Florid

Original reporting
Published Nov 12, 2026, 9:10 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 12, 2026, 9:13 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$OPHC
Bullish
high confidence
Mentioned
$OPHC
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$OPHCBullishHigh
01

Why it matters

The earnings release highlights revenue growth, improved net interest margin, and a new subordinated debt offering, indicating a stronger balance sheet and earnings trajectory.

02

Market read

First‑report earnings for a regional bank; provides fresh data for traders evaluating small‑cap financial stocks.

03

What to watch

Potential headwinds from rising interest‑rate environment and higher non‑interest expenses could temper upside.

Relevance 7/10Novelty 8/10Timing: post‑market release; webcast next morning

Background

OptimumBank Holdings (NYSE American: OPHC) is a Florida‑chartered bank holding company that filed its Q3 2026 results via an SEC Form 8‑K.

Company-level read

Ticker impact

$OPHCBullishHigh confidence
Context

The 8‑K discloses OptimumBank Holdings' Q3 2026 earnings, reporting net income of $7.2 M and EPS of $0.30, up from prior periods.

Expected impact

likely modest upside as investors price in earnings beat and capital raise.

Evidence & confidence

Quarterly results exceed prior quarters, net interest margin improved, and a $35 M debt offering adds capital, supporting earnings momentum.

Market effects

Shows strength in regional community banking sector and may lift peer small‑bank stocks.

Positive for Florida‑based financial institutions and regional lenders.

Limited; primarily a domestic banking story.

Counterpoint

If the market has already priced the earnings beat, the stock could face short‑term profit‑taking.

Key entities

  • Moishe Gubin

    Chairman and CEO of OptimumBank Holdings, quoted on earnings performance.

Related articles

$OPHCMed

OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2026

OptimumBank Holdings, Inc. (OPHC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex99-1.htm EX-99.1 Exhibit 99.1 OptimumBank Holdings, Inc. Financial Performance for the Second Quarter of 2026 Fort Lauderdale, FL, July 24, 2026 — OptimumBank Holdings, Inc. (NYSE American: OPHC) (the “Company”) is a financial holding company and owns 100% of OptimumB

$PTHSMed

Pelthos (PTHS) Q3 2026 Earnings Call Transcript

Pelthos (PTHS) reported Q3 2026 net revenue of $15.2M, up 114% YoY, with Zelsuvmi treating 31,000 patients. Formulary coverage expanded to 70% of commercial lives. The company announced a deal with Castle Creek Biosciences, aiming to leverage synergies in dermatology and cell/gene therapy markets. Xepi and Xeglyze launches are planned for 2027.

$BMNRMedAI 8/10

Bitmine’s ($BMNR) $6.3 Billion Loss Highlights Overall Risks for Strategy ($MSTR) and Other Treasury Firms as MSCI Tightens Rules

Bitmine Immersion Technologies (BMNR) reported a $6.3B net loss for fiscal 2026, driven by $6.23B in unrealized losses on digital-asset holdings, primarily ether. The company held 5.9M ether tokens and 211 bitcoin at year-end. Operating revenue was $125M, with staking contributing 97%. MSCI's updated index rules may impact BMNR and other crypto-focused treasury firms, including Strategy (MSTR).

HighAI 8/10

Merck KGaA Earnings Call Signals Stronger Growth Ahead

Merck KGaA (MKKGY) reported Q3 earnings with accelerated growth, raised full-year guidance, and announced strategic investments. Key highlights include 5.1% organic sales growth, EUR 1.66B operating cash flow, and plans to acquire Silence Therapeutics. Management emphasized growth in biomanufacturing, semiconductors, and rare diseases, while noting Mavenclad's declining sales and softer demand in consumer electronics.